Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses

• Maki Kiso,

  Affiliation Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan

  ⨯
• Shuku Kubo,

  Affiliation Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan

  ⨯
• Makoto Ozawa,

  Affiliations International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• Quynh Mai Le,

  Affiliation National Institute of Hygiene and Epidemiology, Hanoi, Vietnam

  ⨯
• Chairul A. Nidom,

  Affiliation Faculty of Veterinary Medicine, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia

  ⨯
• Makoto Yamashita,

  Affiliation Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan

  ⨯
• Yoshihiro Kawaoka

  * E-mail: kawaoka@ims.u-tokyo.ac.jp

  Affiliations Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin, United States of America, ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan, International Center for Medical Research and Treatment, Graduate School of Medicine, Kobe University, Chuo-ku, Hyogo, Japan

  ⨯